IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
528.77
+6.07 (1.16%)
At close: Jun 16, 2025, 4:00 PM
529.76
+0.99 (0.19%)
After-hours: Jun 16, 2025, 4:39 PM EDT
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $998.43M in the quarter ending March 31, 2025, with 3.56% growth. This brings the company's revenue in the last twelve months to $3.93B, up 5.56% year-over-year. In the year 2024, IDEXX Laboratories had annual revenue of $3.90B with 6.46% growth.
Revenue (ttm)
$3.93B
Revenue Growth
+5.56%
P/S Ratio
11.03
Revenue / Employee
$357,440
Employees
11,000
Market Cap
42.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
IDXX News
- 11 days ago - Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders - PRNewsWire
- 4 weeks ago - IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits - Seeking Alpha
- 4 weeks ago - IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day - Business Wire
- 6 weeks ago - IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 6 weeks ago - IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics - Reuters
- 6 weeks ago - IDEXX Laboratories Announces First Quarter Results - Business Wire
- 2 months ago - IDEXX Laboratories to Release 2025 First Quarter Financial Results - Business Wire
- 3 months ago - IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy' - Seeking Alpha